Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Small study hopes to personalize anesthesia for liver transplant patients

NCT ID NCT06909942

First seen Jan 04, 2026 · Last updated Jun 13, 2026 · Updated 23 times

Summary

This completed study looked at 3 liver transplant patients to see if muscle loss (sarcopenia) changes how the body responds to the muscle relaxant rocuronium. Researchers measured hand grip strength and used a questionnaire to diagnose sarcopenia before surgery, then tracked how long the drug lasted. The goal was to find if lower doses could be used safely, potentially reducing time spent in the hospital and on a ventilator.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Turgut Ozal Medicine Center Liver Transplantation Institute

    Malatya, Battalgazi, 44040, Turkey (Türkiye)

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.